MEDICAL DEVICES & CLINICAL

Medical Device Post-Installation Clinical Satisfaction & Formulary Retention Survey

Measure how clinical procurement leads, biomedical engineers, and formulary committee members evaluate device performance, integration outcomes, and vendor support, so you can sharpen retention positioning, fix renewal conversion gaps, and benchmark formulary standing.

Multi-Hospital sample
Clinical procurement teams (Formulary & Biomedical Leads)
15-20 min
Talk to a Survey Consultant
Retention signals & drop-off triggersIdentify where clinical satisfaction erodes and formulary renewal decisions stall.
Performance benchmarks & trade-offsRank device attributes against competing vendors across key formulary criteria.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most medical device commercial teams don't lose formulary position purely on clinical performance. They lose it due to unresolved installation friction, inadequate clinical training, slow field service response, misaligned reorder protocols, and weak in-service follow-through, none of which fully show up in CRM activity logs or post-sale service tickets.

If you are...

  • Capital equipment commercial leader
  • Diagnostics vs imaging competitor
  • Clinical Affairs or Medical Science head
  • Hospital accounts retention lead
  • Formulary and procurement strategy team

You're likely facing...

  • Post-installation satisfaction drop-off
  • Formulary review: renewal vs replacement
  • OEM fit confusion: domestic vs imported
  • Clinical champion disengagement mid-cycle
  • Reorder stall: budget vs preference gap

This will help answer...

  • Clinical satisfaction drivers post-installation
  • Formulary drop-off stage and trigger
  • Segment preference by device category
  • Service contract renewal vs switch signals
  • Pricing tension at reorder decision

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete clinical device journey from installation to formulary retention.

TENETS 01

Installation & Onboarding

  • Commissioning timeline, site readiness
  • Biomedical engineer training completion
TENETS 02

Clinical Performance

  • Diagnostic accuracy, workflow integration
  • Adverse event rate, clinical downtime
TENETS 03

User Satisfaction

  • Clinician adoption rate, ease of use
  • Operator confidence, interface friction
TENETS 04

Service & Support

  • Field service response time, parts availability
  • Remote diagnostics, helpdesk resolution rate
TENETS 05

Training & Competency

  • In-service training frequency, curriculum gaps
  • Competency assessment, re-certification cycles
TENETS 06

Contract & Pricing

  • AMC coverage, consumable cost burden
  • Tender renewal timing, pricing benchmarks
TENETS 07

Formulary Retention

  • Formulary review triggers, committee criteria
  • Incumbent loyalty, switching consideration
TENETS 08

Advocacy & Referral

  • Peer recommendation intent, KOL engagement
  • Reference site willingness, case study participation

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Medical Device Post-Installation Clinical Satisfaction and Formulary Retention Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Measuring clinical satisfaction scores post-installation
2
Ranking formulary retention drivers by device category
3
Comparing responses across facility type and specialty
Deliverables
Satisfaction score matrix
Retention driver ranking
Segment comparison report
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Biomedical engineers and procurement heads in smaller facilities
2
Quick coverage across regional and district-level hospitals
Deliverables
Facility-tier coverage
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
High-value accounts with complex multi-device installations
2
Clinical department heads requiring in-person verification
Deliverables
Account-level insights
Clinical workflow maps
OPTIONAL
FGDs
Deliverables
Themes and quotes
Concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting clinical end-users and procurement leads across hospital tiers, supported by CATI for smaller facilities with low digital engagement.
Consider adding: F2F interviews for high-value accounts managing multi-device installations, and a focused FGD layer to pressure-test formulary retention messaging and identify service gap narratives.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the medical device clinical adoption space.

CASELET 1

Clinician adoption barriers for capital equipment in hospital networks (India)

CASELET 2

Formulary committee decision criteria for diagnostic consumables (Southeast Asia)

Clinician adoption barriers for capital equipment in hospital networks (India)

OBJECTIVE

A mid-size medical device distributor needed to isolate why interventional cardiologists and cath lab coordinators in Tier 1 and Tier 2 hospitals deprioritised a newly installed imaging system during case scheduling decisions within the first 90 days post-installation.

WHAT WE DID

Ran a structured quant survey across 180 clinicians in 24 hospital networks, capturing device utilisation frequency, training adequacy scores, peer recommendation intent, and preference ranking against incumbent systems by department type and bed capacity.

DELIVERED

A utilisation friction map by clinician role, a training gap index segmented by hospital tier, a ranked list of adoption blockers by device category, and a set of re-engagement levers tied to specific post-installation touchpoints.
CASELET 1

Clinician adoption barriers for capital equipment in hospital networks (India)

CASELET 2

Formulary committee decision criteria for diagnostic consumables (Southeast Asia)

Clinician adoption barriers for capital equipment in hospital networks (India)

OBJECTIVE

A mid-size medical device distributor needed to isolate why interventional cardiologists and cath lab coordinators in Tier 1 and Tier 2 hospitals deprioritised a newly installed imaging system during case scheduling decisions within the first 90 days post-installation.

WHAT WE DID

Ran a structured quant survey across 180 clinicians in 24 hospital networks, capturing device utilisation frequency, training adequacy scores, peer recommendation intent, and preference ranking against incumbent systems by department type and bed capacity.

DELIVERED

A utilisation friction map by clinician role, a training gap index segmented by hospital tier, a ranked list of adoption blockers by device category, and a set of re-engagement levers tied to specific post-installation touchpoints.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between acute care hospitals, ambulatory surgical centers and integrated health networks?

How will you measure formulary retention preference beyond simple ratings?

Will the survey map the full post-installation clinical adoption journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our formulary retention and contract renewal rate?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call